Introduction: Studies have shown a shift in the prevalence from Gram-positive to Gram-
negative bacteraemia in patients with haematological malignancies who develop febrile …

Background and Purpose: The microbiological spectrum in cancer patients with febrile
neutropenia has changed over the past several decades in western countries. The growing …

Febrile neutropenia is a medical emergency that complicates the clinical course and
treatment of haematological malignancies, significantly enhancing the financial burden and …

Background: Bloodstream infections are the major cause of life-threatening complications in
febrile neutropenic patients with hematolymphoid malignancies. The prevalence of these …

Background: The aim of this study was to study clinical profile with bacterial spectrum and
susceptibility patterns of pathogens in culture positive febrile neutropenic (FN) patients of …

Introduction: Bloodstream infections with multidrug-resistant (MDR) Gram-negative bacteria
(GNB) are among the most frequent complications in immunocompromised cancer patients …

Background. Febrile neutropenia is the consequence of treatment of hematological
disorders. The first‐line empirical treatment should cover the prevalent microorganism of the …

Background: An appropriate regimen in the empirical therapy of neutropenic fever episodes
must be individualized at each institution. Hospitals have different patterns of microbial …

Background The use of ill-suited antibiotics is a significant risk factor behind the increase in
the mortality, morbidity, and economic burden for patients who are under treatment for …

Background: Bacterial infections are the major cause of morbidity and mortality among
neutropenic patients. Prompt administration of empiric antimicrobial therapy for febrile …